Our company is focused on developing a new imaging technology to improve biological research and, ultimately, health outcomes, across all of biology, enabling previously impossible applications. We deliver detailed breakdowns on a cell-by-cell basis, by using deep learning to classify cells based on their morphology. We've launched an internal product and are working to develop a commercially releasable version.